Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome

被引：7
|
作者：
Busutti, Marco [1 ,2 ]
Diomedi-Camassei, Francesca [3 ]
Donadelli, Roberta [4 ]
Mele, Caterina [4 ]
Emma, Francesco [1 ]
Vivarelli, Marina [1 ]
机构：
[1] IRCCS Osped Pediat Bambino Gest, Div Nephrol, Dept Pediat Subspecialties, Rome, Italy
[2] Univ Bologna, Nephrol Dialysis & Transplant Unit, Policlin St Orsola, Via Massarenti 9, I-40137 Bologna, Italy
[3] IRCCS Osped Pediat Bambino Gest, Pathol Unit, Dept Labs, Rome, Italy
[4] Res Inst Mario Negri IRCCS, Clin Res Ctr Rare Dis Aldo & Cele Dacco & Ctr Ann, Sci & Technol Pk Kilometro Rosso, Bergamo, Italy
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 02期
关键词：
D O I：
10.1016/j.ekir.2020.10.037
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：534 / 537
页数：4
相关论文
共 50 条
  • [1] Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome
    Jozsi, Mihaly
    Reuter, Stefanie
    Nozal, Pilar
    Lopez-Trascasa, Margarita
    Sanchez-Corral, Pilar
    Prohaszka, Zoltan
    Uzonyi, Barbara
    [J]. IMMUNOLOGY LETTERS, 2014, 160 (02) : 163 - 171
  • [2] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy
    Parra, Alba Pau
    Ramos, Natalia
    Perurena-Prieto, Janire
    Manrique-Rodriguez, Silvia
    Climente, Monica
    Quintanilla, Laura Garcia
    Escolano, Angel
    Miarons, Marta
    [J]. FARMACIA HOSPITALARIA, 2024, 48 (01) : T16 - T22
  • [3] Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3
    Ferreira, Emanuel
    Oliveira, Nuno
    Marques, Maria
    Francisco, Luis
    Santos, Ana
    Carreira, Armando
    Campos, Mario
    [J]. NEFROLOGIA, 2016, 36 (01): : 72 - 75
  • [4] Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
    Ellithi, Moataz
    Shahid, Mahum
    Abdullah, Hafez Mohammad
    Bleeker, Jonathan
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (03) : 364 - 367
  • [5] C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction
    Bajwa, Ravneet
    DePalma, John A.
    Khan, Taimoor
    Cheema, Anmol
    Kalathil, Sheila A.
    Hossain, Mohammad A.
    Haroon, Attiya
    Madhurima, Anne
    Zheng, Min
    Nayer, Ali
    Asif, Arif
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2018, 8 (01): : 25 - 34
  • [6] Case report: C3 glomerulopathy advancing atypical hemolytic uremic syndrome
    Catikkas, Muge
    Demir, Erol
    Ozluk, Yasemin
    Caliskan, Yasar
    Badur, Rabia Muberra
    Turkmen, Aydin
    [J]. NEFROLOGIA, 2018, 38 (04): : 450 - 452
  • [7] C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders
    Turkmen, Kultigin
    Baloglu, Ismail
    Ozer, Hakan
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (10) : 2067 - 2080
  • [8] Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
    Mache, Christoph J.
    Acham-Roschitz, Birgit
    Fremeaux-Bacchi, Veronique
    Kirschfink, Michael
    Zipfel, Peter F.
    Roedl, Siegfried
    Vester, Udo
    Ring, Ekkehard
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1312 - 1316
  • [9] C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders
    Kultigin Turkmen
    Ismail Baloglu
    Hakan Ozer
    [J]. International Urology and Nephrology, 2021, 53 : 2067 - 2080
  • [10] Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
    Perkins, Stephen J.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (02) : 120 - +
12345